Cruciferous Vegetable Intervention to Reduce the Risk of Cancer Recurrence in Non-Muscle-Invasive Bladder Cancer Survivors: Development Using a Systematic Process
- PMID: 35166681
- PMCID: PMC8889476
- DOI: 10.2196/32291
Cruciferous Vegetable Intervention to Reduce the Risk of Cancer Recurrence in Non-Muscle-Invasive Bladder Cancer Survivors: Development Using a Systematic Process
Abstract
Background: Bladder cancer is one of the top 10 most common cancers in the United States. Most bladder cancers (70%-80%) are diagnosed at early stages as non-muscle-invasive bladder cancer (NMIBC), which can be removed surgically. However, 50% to 80% of NMIBC cases recur within 5 years, and 15% to 30% progress with poor survival. Current treatments are limited and expensive. A wealth of preclinical and epidemiological evidence suggests that dietary isothiocyanates in cruciferous vegetables (Cruciferae) could be a novel, noninvasive, and cost-effective strategy to control NMIBC recurrence and progression.
Objective: The aim of this study is to develop a scalable dietary intervention that increases isothiocyanate exposure through Cruciferae intake in NMIBC survivors.
Methods: We worked with a community advisory board (N=8) to identify relevant factors, evidence-based behavior change techniques, and behavioral theory constructs used to increase Cruciferae intake in NMIBC survivors; use the PEN-3 Model focused on incorporating cultural factors salient to the group's shared experiences to review the intervention components (eg, the saliency of behavioral messages); administer the revised intervention to community partners for their feedback; and refine the intervention.
Results: We developed a multicomponent intervention for NMIBC survivors consisting of a magazine, tracking book, live telephone call script, and interactive voice messages. Entitled POW-R Health: Power to Redefine Your Health, the intervention incorporated findings from our adaptation process to ensure saliency to NMIBC survivors.
Conclusions: This is the first evidence-based, theoretically grounded dietary intervention developed to reduce bladder cancer recurrence in NMIBC survivors using a systematic process for community adaptation. This study provides a model for others who aim to develop behavioral, community-relevant interventions for cancer prevention and control with the overall goal of wide-scale implementation and dissemination.
Keywords: cancer recurrence; cancer survivorship; cruciferous vegetable; dietary intervention; non–muscle invasive bladder cancer survivors.
©Karen H Kim Yeary, Nikia Clark, Frances Saad-Harfouche, Deborah Erwin, Margaret Gates Kuliszewski, Qiang Li, Susan E McCann, Han Yu, Catherine Lincourt, Jamie Zoellner, Li Tang. Originally published in JMIR Cancer (https://cancer.jmir.org), 15.02.2022.
Conflict of interest statement
Conflicts of Interest: None declared.
Similar articles
-
Outcomes of a Dietary Intervention to Reduce Bladder Cancer Recurrence and Progression in Survivors of Non-Muscle-Invasive Bladder Cancer.J Natl Compr Canc Netw. 2024 Feb 26;22(2):e237086. doi: 10.6004/jnccn.2023.7086. J Natl Compr Canc Netw. 2024. PMID: 38408431 Free PMC article. Clinical Trial.
-
Description of a cruciferous vegetable intervention trial to test the efficacy of a maintenance component to reduce bladder cancer recurrence and progression.Contemp Clin Trials. 2025 Sep;156:108036. doi: 10.1016/j.cct.2025.108036. Epub 2025 Jul 30. Contemp Clin Trials. 2025. PMID: 40750073
-
Associations of dietary isothiocyanate exposure from cruciferous vegetable consumption with recurrence and progression of non-muscle-invasive bladder cancer: findings from the Be-Well Study.Am J Clin Nutr. 2023 Jun;117(6):1110-1120. doi: 10.1016/j.ajcnut.2023.04.006. Epub 2023 Apr 11. Am J Clin Nutr. 2023. PMID: 37044209 Free PMC article.
-
Quality of Life in Non-Muscle-Invasive Bladder Cancer Survivors: A Systematic Review.Cancer Nurs. 2019 May/Jun;42(3):E21-E33. doi: 10.1097/NCC.0000000000000606. Cancer Nurs. 2019. PMID: 29863576
-
Enhanced Visualization Methods for First Transurethral Resection of Bladder Tumour in Suspected Non-muscle-invasive Bladder Cancer: A Health Technology Assessment.Ont Health Technol Assess Ser. 2021 Aug 12;21(12):1-123. eCollection 2021. Ont Health Technol Assess Ser. 2021. PMID: 34484486 Free PMC article.
Cited by
-
Mechanistic review of sulforaphane as a chemoprotective agent in bladder cancer.Am J Clin Exp Urol. 2023 Apr 15;11(2):103-120. eCollection 2023. Am J Clin Exp Urol. 2023. PMID: 37168941 Free PMC article. Review.
-
Outcomes of a Dietary Intervention to Reduce Bladder Cancer Recurrence and Progression in Survivors of Non-Muscle-Invasive Bladder Cancer.J Natl Compr Canc Netw. 2024 Feb 26;22(2):e237086. doi: 10.6004/jnccn.2023.7086. J Natl Compr Canc Netw. 2024. PMID: 38408431 Free PMC article. Clinical Trial.
-
Drugs Targeting p53 Mutations with FDA Approval and in Clinical Trials.Cancers (Basel). 2023 Jan 9;15(2):429. doi: 10.3390/cancers15020429. Cancers (Basel). 2023. PMID: 36672377 Free PMC article. Review.
-
Allyl-, Butyl- and Phenylethyl-Isothiocyanate Modulate Akt-mTOR and Cyclin-CDK Signaling in Gemcitabine- and Cisplatin-Resistant Bladder Cancer Cell Lines.Int J Mol Sci. 2022 Sep 20;23(19):10996. doi: 10.3390/ijms231910996. Int J Mol Sci. 2022. PMID: 36232303 Free PMC article.
-
Description of a cruciferous vegetable intervention trial to test the efficacy of a maintenance component to reduce bladder cancer recurrence and progression.Contemp Clin Trials. 2025 Sep;156:108036. doi: 10.1016/j.cct.2025.108036. Epub 2025 Jul 30. Contemp Clin Trials. 2025. PMID: 40750073
References
-
- National Cancer Institute. [2022-01-28]. https://tinyurl.com/4524spfb .
-
- Holmäng S, Hedelin H, Anderström C, Johansson SL. The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. J Urol. 1995 Jun;153(6):1823–6; discussion 1826.S0022-5347(01)67321-X - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous